Integrating evolutionary dynamics into cancer therapy.

Nature Reviews. Clinical Oncology
Robert A Gatenby, Joel S Brown

Abstract

Many effective drugs for metastatic and/or advanced-stage cancers have been developed over the past decade, although the evolution of resistance remains the major barrier to disease control or cure. In large, diverse populations such as the cells that compose metastatic cancers, the emergence of cells that are resistant or that can quickly develop resistance is virtually inevitable and most likely cannot be prevented. However, clinically significant resistance occurs only when the pre-existing resistant phenotypes are able to proliferate extensively, a process governed by eco-evolutionary dynamics. Attempts to disrupt the molecular mechanisms of resistance have generally been unsuccessful in clinical practice. In this Review, we focus on the Darwinian processes driving the eco-evolutionary dynamics of treatment-resistant cancer populations. We describe a variety of evolutionarily informed strategies designed to increase the probability of disease control or cure by anticipating and steering the evolutionary dynamics of acquired resistance.

References

Apr 2, 1999·Science·J K Parrish, L Edelstein-Keshet
Oct 17, 2002·Journal of Theoretical Biology·David S Boukal, Ludek Berec
Dec 22, 2005·Archives of Women's Mental Health·A H ClaytonW Evans
Feb 10, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Scott J AntoniaDmitry I Gabrilovich
Aug 9, 2006·Nature Clinical Practice. Oncology·Richard Simon, Larry Norton
Sep 22, 2006·The Journal of Nutrition·Roderick H Dashwood
Nov 17, 2006·Nature Reviews. Cancer·Lauren M F MerloCarlo C Maley
Jul 6, 1928·Science·B R Headstrom
Aug 20, 1943·Science·J H Pannell
Dec 13, 1968·Science
Oct 20, 2007·The Journal of Pharmacology and Experimental Therapeutics·Fei ShenLeonard C Erickson
May 13, 2008·Nature Reviews. Cancer·Klaus Strebhardt, Axel Ullrich
Nov 1, 2008·Cancer Research·Vincent T DeVita, Edward Chu
May 30, 2009·Nature·Robert A Gatenby
Jun 3, 2009·Cancer Research·Robert A GatenbyB Roy Frieden
Sep 16, 2009·Cancer Research·Robert A GatenbyThomas Vincent
Sep 25, 2009·The New England Journal of Medicine·Hugo F FernandezMartin S Tallman
Dec 10, 2009·Molecular Biology and Evolution·Maurine NeimanDouglas R Taylor
Oct 30, 2010·Journal of Cellular and Molecular Medicine·Yanlei MaHuanlong Qin
May 10, 2011·Nature Reviews. Cancer·Robert A GatenbyJoel S Brown
Jul 8, 2011·Science Translational Medicine·Juliann ChmieleckiWilliam Pao
Aug 3, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Elahe A MostaghelR Bruce Montgomery
Aug 6, 2011·Molecular Pharmaceutics·Jessica J CunninghamJoel S Brown
Mar 1, 2012·Molecular Pharmaceutics·David BasantaAlexander R A Anderson
Mar 9, 2012·The New England Journal of Medicine·Marco GerlingerCharles Swanton
Aug 31, 2012·The New England Journal of Medicine·Juanita M CrookLaurence Klotz
Jan 16, 2013·Nature·Robert Gatenby
Apr 5, 2013·The New England Journal of Medicine·Maha HussainIan M Thompson
Feb 1, 2014·Evolution, Medicine, and Public Health·Marco Archetti
Apr 18, 2014·Nature Reviews. Cancer·Kirill S KorolevJeff Gore
Jul 9, 2014·PloS One·Stephanie M PerkinsHaydar Frangoul
Dec 2, 2014·Pediatric Clinics of North America·Deepa BhojwaniChing-Hon Pui
Jan 28, 2015·Proceedings of the National Academy of Sciences of the United States of America·Marco ArchettiGerhard Christofori
Jan 30, 2015·Proceedings of the National Academy of Sciences of the United States of America·Gunther JansenC Athena Aktipis
Feb 18, 2015·Nature Reviews. Clinical Oncology·Viola WaltherCarlo C Maley

❮ Previous
Next ❯

Citations

Jan 9, 2021·Cancer Biotherapy & Radiopharmaceuticals·J Harvey Turner
Jan 1, 2021·Biochimica Et Biophysica Acta. Molecular Basis of Disease·Marcello CeciNicla Romano
Jan 27, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Bruce C BaguleyGraeme J Finlay
Feb 9, 2021·Cancer Metastasis Reviews·Michaël NoëRalph H Hruban
Nov 4, 2020·Cold Spring Harbor Perspectives in Medicine·Robert A Gatenby, Joel S Brown
Jan 8, 2021·Nature Reviews. Genetics·Mary Lauren BentonJohn A Capra
Dec 5, 2020·Seminars in Cancer Biology·K J PientaS R Amend
Dec 24, 2020·Cancer Research·Luana S LenzGuido Lenz
Apr 14, 2021·Nature Ecology & Evolution·Yannick Viossat, Robert Noble
Apr 27, 2021·Evolutionary Applications·Antoine M DujonBeata Ujvari
May 7, 2021·Molecular Oncology·Matheus Henrique Dias, René Bernards
May 25, 2021·Frontiers in Oncology·Luciana W ZuccheratoPaulo Guilherme O Salles
May 20, 2021·Physical Review. E·Youness AzimzadeRobert A Gatenby
Jun 18, 2021·Physical Review. E·Youness Azimzade, Abbas Ali Saberi
Jul 26, 2021·Journal of Theoretical Biology·Jessie Renton, Karen M Page
Aug 31, 2021·The EMBO Journal·Roberto VendraminCharles Swanton
Oct 3, 2021·Drug Discovery Today·Choong Yong UngHu Li

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Cold Spring Harbor Perspectives in Medicine
Robert A Gatenby, Joel S Brown
Cold Spring Harbor Perspectives in Medicine
Robert A Gatenby, Joel S Brown
Nature Ecology & Evolution
Seth M RudmanJonathan M Levine
Proceedings of the National Academy of Sciences of the United States of America
Karl Sigmund, Robert D Holt
© 2021 Meta ULC. All rights reserved